Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Rybelsus (semaglutide) is an oral GLP-1 receptor agonist used to treat type 2 diabetes in the UK. Whilst fatigue is not listed as a common side effect in the Summary of Product Characteristics, some patients do report feeling tired whilst taking this medication. Tiredness may arise from various factors, including the underlying diabetes itself, changes in eating patterns due to reduced appetite, gastrointestinal side effects, or the body adjusting to improved blood glucose control. If you experience persistent or troublesome tiredness on Rybelsus, it is important to discuss this with your GP or diabetes specialist nurse for proper assessment and guidance.
Summary: Fatigue is not listed as a common side effect of Rybelsus in UK prescribing information, though some patients report tiredness which may relate to diabetes itself, dietary changes, gastrointestinal effects, or metabolic adjustment.
Rybelsus (semaglutide) is an oral glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus. It works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and promotes satiety. These mechanisms help improve glycaemic control and often lead to weight reduction.
Fatigue is not listed as a common adverse reaction in the UK Summary of Product Characteristics (SmPC) for Rybelsus. The most frequently reported side effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, abdominal pain, and constipation. These occur in a significant proportion of patients, particularly during dose titration.
However, some patients do report feeling tired whilst taking Rybelsus. It is important to recognise that tiredness can arise from multiple factors, including the underlying condition being treated (type 2 diabetes itself), changes in eating patterns due to reduced appetite, gastrointestinal side effects affecting nutrition, or concurrent medications. Additionally, improved glycaemic control may initially cause subtle physiological adjustments as the body adapts to more stable blood glucose levels.
If you are experiencing persistent or troublesome tiredness while taking Rybelsus, it is essential to discuss this with your GP or diabetes specialist nurse. They can assess whether the fatigue is related to the medication, your diabetes management, or other health factors, and provide appropriate guidance tailored to your individual circumstances.

If you are experiencing tiredness whilst taking Rybelsus, there are several practical strategies that may help manage this symptom effectively whilst continuing your diabetes treatment.
Optimise your nutrition and hydration:
Ensure you are consuming adequate calories despite reduced appetite, as severe calorie restriction can lead to fatigue
Eat small, frequent, nutrient-dense meals throughout the day rather than large portions
Maintain good hydration, aiming for 6–8 glasses of water daily (follow your clinician's advice if you have been advised to restrict fluids)
Include complex carbohydrates, lean proteins, and healthy fats to sustain energy levels
Consider keeping a food diary to identify if tiredness correlates with inadequate nutritional intake
Address gastrointestinal side effects:
Since nausea, vomiting, and diarrhoea are common with Rybelsus, these symptoms may indirectly contribute to fatigue by affecting your ability to eat properly or causing dehydration. Speak with your healthcare provider about strategies to minimise these effects, such as taking the medication correctly (on an empty stomach with no more than 120ml of plain water, swallowing the tablet whole without splitting, crushing or chewing, and waiting at least 30 minutes before eating, drinking or taking other oral medicines). Anti-emetic medications should only be used following clinical advice due to potential contraindications or interactions.
Monitor your blood glucose levels:
Both hypoglycaemia (low blood sugar) and hyperglycaemia (high blood sugar) can cause tiredness. Regular blood glucose monitoring can help identify patterns. The risk of hypoglycaemia is increased when Rybelsus is used alongside sulphonylureas or insulin. If you are experiencing frequent low blood glucose episodes, discuss dose adjustments with your diabetes team.
Maintain regular physical activity:
Whilst it may seem counterintuitive, regular moderate exercise can actually improve energy levels and reduce fatigue. The NHS recommends at least 150 minutes of moderate-intensity activity per week for adults with type 2 diabetes, plus muscle-strengthening activities on at least 2 days per week. Start gradually if you are not currently active, and consult your healthcare team before beginning any new exercise programme.
Whilst mild tiredness may be manageable with lifestyle adjustments, certain features warrant prompt medical assessment to rule out potentially serious underlying causes or complications.
Contact your GP or diabetes specialist nurse if you experience:
Severe or worsening fatigue that significantly impacts your daily activities or quality of life
Persistent tiredness that does not improve after several weeks despite self-management strategies
Symptoms suggesting hypoglycaemia, including shakiness, sweating, confusion, palpitations, or hunger alongside tiredness
Signs of dehydration, such as dark urine, dizziness, dry mouth, or reduced urine output, particularly if accompanied by vomiting or diarrhoea
Unexplained weight loss beyond what would be expected from improved diabetes control
New or worsening symptoms such as shortness of breath, chest pain, or palpitations
Visual changes or deterioration, as rapid improvement in blood glucose can sometimes worsen diabetic retinopathy
Right upper abdominal pain, fever, yellowing of skin/eyes or pale stools, which could indicate gallbladder disease (a known risk with GLP-1 receptor agonists)
Seek urgent medical attention (call 999 or attend A&E) if you develop:
Severe abdominal pain that does not resolve, particularly if radiating to the back (potential pancreatitis)
Signs of severe dehydration with inability to keep fluids down
Altered consciousness or severe confusion
Symptoms of diabetic ketoacidosis (though rare in type 2 diabetes), including excessive thirst, frequent urination, fruity breath odour, and rapid breathing
For urgent but non-life-threatening concerns, contact NHS 111 for advice.
Your healthcare provider may wish to investigate potential causes of fatigue through blood tests, including full blood count (to check for anaemia), thyroid function tests, vitamin B12, folate and ferritin levels, renal function, and HbA1c to assess overall diabetes control. According to NICE guidance on type 2 diabetes management, regular monitoring and individualised treatment adjustments are essential to optimise outcomes whilst minimising adverse effects.
If you suspect your tiredness may be a side effect of Rybelsus, you can report this through the MHRA Yellow Card scheme, which helps monitor medication safety.
When experiencing fatigue whilst taking Rybelsus, it is important to consider that tiredness may not be directly caused by the medication itself but rather by other factors related to your diabetes, general health, or lifestyle.
Diabetes-related causes:
Type 2 diabetes itself is a common cause of fatigue. Poor glycaemic control, whether blood glucose levels are too high or too low, can lead to tiredness. Hyperglycaemia causes the body to work harder to eliminate excess glucose through urine, leading to dehydration and energy depletion. Conversely, hypoglycaemia deprives the brain and muscles of their primary fuel source. Additionally, diabetes-related complications such as diabetic neuropathy, cardiovascular disease, or kidney impairment can contribute to persistent fatigue.
Nutritional deficiencies:
Patients with type 2 diabetes, particularly those taking metformin (often prescribed alongside Rybelsus), may develop vitamin B12 deficiency, which causes fatigue and weakness. The MHRA has issued a Drug Safety Update highlighting this risk, and testing should be considered if you are symptomatic. Iron deficiency anaemia is another common cause of tiredness that can be identified through blood tests. The appetite suppression caused by Rybelsus may inadvertently lead to inadequate intake of essential nutrients if dietary choices are not carefully managed. A referral to a dietitian may be helpful if this is a concern.
Concurrent medical conditions:
Many conditions commonly coexist with type 2 diabetes and cause fatigue, including:
Hypothyroidism (underactive thyroid) – more common in people with diabetes than in the general population
Obstructive sleep apnoea – more prevalent in individuals with obesity; discuss with your GP if you have symptoms such as loud snoring, breathing pauses during sleep, or excessive daytime sleepiness
Depression and anxiety – psychological conditions frequently associated with chronic disease
Chronic kidney disease – a potential complication of diabetes
Cardiovascular disease – heart failure or coronary artery disease can cause fatigue
Medication interactions:
Review all your medications with your pharmacist or GP, as some drugs can cause tiredness as a side effect. Beta-blockers, certain blood pressure medications, antihistamines, and some pain medications are known to cause fatigue.
Lifestyle factors:
Poor sleep quality, inadequate physical activity, high stress levels, and excessive alcohol consumption can all contribute to persistent tiredness. A comprehensive assessment by your healthcare team can help identify and address these multiple potential contributors to fatigue, ensuring your diabetes treatment plan is optimised whilst maintaining your overall wellbeing and quality of life.
Fatigue is not listed as a common adverse reaction in the UK Summary of Product Characteristics for Rybelsus. The most frequently reported side effects are gastrointestinal symptoms such as nausea, vomiting, and diarrhoea, though some patients do report tiredness which may be related to various factors including dietary changes or blood glucose fluctuations.
Ensure adequate nutrition and hydration, monitor your blood glucose levels regularly, and maintain physical activity as recommended by your healthcare team. If tiredness persists or worsens, contact your GP or diabetes specialist nurse for assessment, as fatigue may indicate hypoglycaemia, dehydration, nutritional deficiencies, or other underlying conditions requiring investigation.
Rybelsus alone has a low risk of hypoglycaemia because it stimulates insulin release in a glucose-dependent manner. However, when combined with sulphonylureas or insulin, the risk of low blood sugar increases, and hypoglycaemia can cause tiredness alongside other symptoms such as shakiness, sweating, and confusion.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript